Banjo Health vs Xsolis
Two well credentialed vendors working different determinations. Banjo is pharmacy benefit weighted, reading prescriber notes directly and producing a structured recommendation with the evidence attached rather than an opaque score, backed by certification at the more demanding risk based tier. Xsolis works medical necessity and does something nobody else in this index does: it sits between payer and provider, scoring continuously so both sides argue from the same number, with peer reviewed research behind that score. The shared score is the more interesting idea, because most utilization disputes are arguments about evidence rather than rules. Neither publishes what proportion of AI informed adverse determinations get overturned on appeal, which is the number that would show either side is calibrated.
- It is pharmacy benefit weighted and reads prescriber notes directly, producing an inspectable structured recommendation with evidence attached rather than a score.
- Certification is held at the risk based two year tier, which incorporates privacy requirements and is the more demanding assessment.
- For a pharmacy benefit operation, the formulary determination workflow differs from medical necessity and this is built for it.
- It sits between payer and provider rather than serving one side, scoring medical necessity continuously so both parties argue from the same number.
- It is the only vendor in this cluster with peer reviewed research behind its score, published across multiple health systems.
- A risk based certification at the two year tier is matched by the strongest security posture in this part of the index.
Side by Side
| Axis | B Banjo Health |
X Xsolis |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Utilization management is the one lane in this index where an AI output can end in care being denied, and neither vendor publishes a bias evaluation or subgroup performance analysis. Neither publishes the calibration number for its own side: the proportion of AI informed adverse determinations overturned on appeal.
A carrier remains responsible for prior authorization compliance regardless of which vendor performed the work, and at least one state requires the programme to meet a recognised accreditation standard, so establish which accreditations apply to the specific programme you are buying.